$17.20
-0.09-0.52%
Pre-Market: Feb 28, 8:59 AM EDT
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
ProShares UltraShort Nasdaq Biotechnology Stock Price, Quotes and Forecasts
BISNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Unknown
Region
US
AUM
3.07M
Fund Score
ProShares UltraShort Nasdaq Biotechnology Price, Quotes and Forecasts | NASDAQ:BIS | Benzinga
Explore ProShares UltraShort Nasdaq Biotechnology stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BIS.
| Open | - |
| High | - |
| 52 Wk High | $21.10 |
| AUM | 3.07M |
| Dividend | $0.61 |
| Ex-Div Date | Jun 26, 2024 |
| Volume | - |
| Market Cap | - |
| Mgmt Fee | 0.75% |
| P/E Ratio | - |
| Prev. Close | $17.29 |
| Low | - |
| 52 Wk Low | $14.05 |
| Shares Out | 171.10K |
| Yield | 3.92% |
| Div. Freq | U |
| Avg. Volume Daily | 8.96K |
| Beta | -1.15 |
| Avg. Expense Ratio | 0.95% |
| P/B Ratio | - |
Recent News
FAQ
Q
How do I buy ProShares UltraShort Nasdaq Biotechnology (BIS) stock?
A
You can purchase shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) through any online brokerage.
Q
Who are ProShares UltraShort Nasdaq Biotechnology (BIS) competitors?
A
There are no as such competitors for ProShares UltraShort Nasdaq Biotechnology.
Q
What is the forecast, or price target, for ProShares UltraShort Nasdaq Biotechnology (BIS) stock?
A
There is no analysis for ProShares UltraShort Nasdaq Biotechnology to provide a consensus price target.
Q
What is the current price for ProShares UltraShort Nasdaq Biotechnology (BIS)?
A
The stock price for ProShares UltraShort Nasdaq Biotechnology (NASDAQ: BIS) is $17.2 last updated February 28, 2025 at 8:59 AM EST.
Q
Does ProShares UltraShort Nasdaq Biotechnology (BIS) pay a dividend?
A
A quarterly cash dividend of 0.15 per share of Class A Common Stock. The quarterly cash dividend was payable on October 2, 2024 to stockholders of record on September 25, 2024.
Q
When is ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) reporting earnings?
A
ProShares UltraShort Nasdaq Biotechnology does not have any upcoming earnings scheduled.
Q
Is ProShares UltraShort Nasdaq Biotechnology (BIS) going to split?
A
There is no upcoming split for ProShares UltraShort Nasdaq Biotechnology.
| Open | - |
| High | - |
| 52 Wk High | $21.10 |
| AUM | 3.07M |
| Dividend | $0.61 |
| Ex-Div Date | Jun 26, 2024 |
| Volume | - |
| Market Cap | - |
| Mgmt Fee | 0.75% |
| P/E Ratio | - |
| Prev. Close | $17.29 |
| Low | - |
| 52 Wk Low | $14.05 |
| Shares Out | 171.10K |
| Yield | 3.92% |
| Div. Freq | U |
| Avg. Volume Daily | 8.96K |
| Beta | -1.15 |
| Avg. Expense Ratio | 0.95% |
| P/B Ratio | - |
About ProShares Trust
Sector
N/A
Industry
N/A
ETF Details
| Sector | Unknown |
| Category | - |
| Investment Style | Trading-Inverse Equity |
| Fund Inception | Apr 6, 2010 |
| Managers | Tarak Dave Michael Neches |
| Definition | - |
Investment Policy
The Fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The Index is constructed and maintained by Nasdaq Inc. (the Index Provider). The Index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by the Index Provider, including minimum market capitalization and liquidity requirements.
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2025 Benzinga | All Rights Reserved